Seoul, South Korea

Yun Soo Yoon

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Soo Yoon. Retrieved from https://idiyas.com/inventor/yun-soo-yoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 75.0


 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 71(Granted Patents)


Location History:

  • Seoul, KR (2011 - 2015)
  • Gyeonggi-do, KR (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Yun Soo Yoon - Revolutionizing Technology in Seoul

Introduction: Yun Soo Yoon is a visionary inventor based in Seoul, South Korea, known for his groundbreaking contributions to the field of technology.

Latest Patents: Yun Soo Yoon holds several patents in the areas of artificial intelligence, robotics, and renewable energy, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Yun Soo Yoon has worked with leading tech companies in South Korea, spearheading projects that have pushed the boundaries of technological advancements.

Collaborations: Throughout his career, Yun Soo Yoon has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and creativity.

Conclusion: Inventor Yun Soo Yoon's relentless pursuit of innovation and his passion for technology continue to inspire the next generation of inventors and shape the future of technology in Seoul and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…